呼吸道合胞病毒融合基因的分子进化，加拿大，2006-2010 年。
Molecular evolution of respiratory syncytial virus fusion gene, Canada, 2006-2010.
机构信息
McGill University Health Centre, Montréal, Québec, Canada.
出版信息
Emerg Infect Dis. 2012 Jan;18(1):120-4. doi: 10.3201/eid1801.110515.
Abstract
To assess molecular evolution of the respiratory syncytial virus (RSV) fusion gene, we analyzed RSV-positive specimens from 123 children in Canada who did or did not receive RSV immunoprophylaxis (palivizumab) during 2006-2010. Resistance-conferring mutations within the palivizumab binding site occurred in 8.7% of palivizumab recipients and none of the nonrecipients.
摘要
为评估呼吸道合胞病毒（RSV）融合基因的分子进化，我们分析了 2006 年至 2010 年期间加拿大 123 名接受或未接受 RSV 免疫预防（帕利珠单抗）的 RSV 阳性患儿的标本。帕利珠单抗结合部位的耐药相关突变仅发生于 8.7%的帕利珠单抗接受者，而未接受者均无此突变。
Zotero 插件